Clotrimazole and Betamethasone Dipropionate Cream USP — Class III drug recall D-1743-2019
Terminated recall by Glenmark Pharmaceuticals Inc., USA, reported 2019-08-21, distributed nationwide. Temperature Abuse: Complaints received of liquidy texture.
| Recall number | D-1743-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2019-08-07 |
| Classified | 2019-08-15 |
| Reported by FDA | 2019-08-21 |
| Terminated | 2020-11-09 |
| Distributed | Nationwide (US) |
| Quantity | 31,224 tubes |
| Reason classes | temperature control |
| NDC | 68462-0298, 68462-0298-17, 68462-0298-55 |
| Lot numbers | 05180734 |
| Expiration dates | 2020-03 |
Product
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17
Reason for recall
Temperature Abuse: Complaints received of liquidy texture.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1743-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.